Human cardiac fibroblasts adaptive responses to controlled combined mechanical strain and oxygen changes in vitro

eLife

Volumn 6, Issue , 2017, Pages

  Ugolini, Giovanni Stefano ^a   Pavesi, Andrea ^b,c   Rasponi, Marco ^a   Fiore, Gianfranco Beniamino ^a   Kamm, Roger ^c,d   Soncini, Monica ^a  

^a POLITECNICO DI MILANO   (Italy)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^c SINGAPORE MIT ALLIANCE FOR RESEARCH AND TECHNOLOGY   (Singapore)

^d Massachusetts Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; INTERLEUKIN 1BETA; INTERLEUKIN 6; SCLEROPROTEIN; STROMELYSIN; TUMOR NECROSIS FACTOR; COLLAGEN; CYTOKINE; OXYGEN;

ADAPTIVE IMMUNITY; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; GAS ANALYSIS PARAMETERS; HEART FIBROBLAST; HEART INJURY; HUMAN; HUMAN CELL; HYPOXIA; IMAGE PROCESSING; IMMUNOFLUORESCENCE; OXYGEN CHANGE; OXYGEN TENSION; PHENOTYPE; PROTEIN EXPRESSION; SUPERNATANT; ADAPTATION; CELL CULTURE; CYTOLOGY; DEVICES; FIBROBLAST; MECHANICAL STRESS; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ADAPTATION, PHYSIOLOGICAL; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; CYTOKINES; CYTOLOGICAL TECHNIQUES; FIBROBLASTS; HUMANS; HYPOXIA; OXYGEN; STRESS, MECHANICAL; STRESS, PHYSIOLOGICAL;

EID: 85018866382     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.22847     Document Type: Article

References (91)

1. Agarwal A, Goss JA, Cho A, McCain ML, Parker KK. 2013. Microfluidic heart on a chip for higher throughput pharmacological studies. Lab on a Chip 13:3599–3608. doi: 10.1039/c3lc50350j, PMID: 23807141
2. Ai F, Chen M, Yu B, Yang Y, Xu G, Gui F, Liu Z, Bai X, Chen Z. 2015. Berberine regulates proliferation, collagen synthesis and cytokine secretion of cardiac fibroblasts via AMPK-mTOR-p70S6K signaling pathway. International Journal of Clinical and Experimental Pathology 8:12509–12516. PMID: 26722438
3. Atance J, Yost MJ, Carver W. 2004. Influence of the extracellular matrix on the regulation of cardiac fibroblast behavior by mechanical stretch. Journal of Cellular Physiology 200:377–386. doi: 10.1002/jcp.20034, PMID: 15254965
4. Baum J, Duffy HS. 2011. Fibroblasts and myofibroblasts: what are we talking about? Journal of Cardiovascular Pharmacology 57:376–379. doi: 10.1097/FJC.0b013e3182116e39, PMID: 21297493
5. Bowers SL, Borg TK, Baudino TA. 2010. The dynamics of fibroblast-myocyte-capillary interactions in the heart. Annals of the New York Academy of Sciences 1188:143–152. doi: 10.1111/j.1749-6632.2009.05094.x, PMID: 20201897
6. Brown RD, Jones GM, Laird RE, Hudson P, Long CS. 2007. Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts. Biochemical and Biophysical Research Communications 362:200–205. doi: 10.1016/j.bbrc.2007.08.003, PMID: 17706606
7. Butt RP, Bishop JE. 1997. Mechanical load enhances the stimulatory effect of serum growth factors on cardiac fibroblast procollagen synthesis. Journal of Molecular and Cellular Cardiology 29:1141–1151. doi: 10.1006/jmcc.1996.0347, PMID: 9160866
8. Cartledge JE, Kane C, Dias P, Tesfom M, Clarke L, Mckee B, Al Ayoubi S, Chester A, Yacoub MH, Camelliti P, Terracciano CM. 2015. Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators. Cardiovascular Research 105:260–270. doi: 10.1093/cvr/cvu264, PMID: 25560320
9. Carver W, Nagpal ML, Nachtigal M, Borg TK, Terracio L. 1991. Collagen expression in mechanically stimulated cardiac fibroblasts. Circulation Research 69:116–122. doi: 10.1161/01.RES.69.1.116, PMID: 2054929
10. Clancy RM, Zheng P, O’Mahony M, Izmirly P, Zavadil J, Gardner L, Buyon JP. 2007. Role of hypoxia and cAMP in the transdifferentiation of human fetal cardiac fibroblasts: implications for progression to scarring in autoimmune-associated congenital heart block. Arthritis and Rheumatism 56:4120–4131. doi: 10.1002/art.23061, PMID: 18050204
11. Codelia VA, Sun G, Irvine KD. 2014. Regulation of YAP by mechanical strain through jnk and hippo signaling. Current Biology 24:2012–2017. doi: 10.1016/j.cub.2014.07.034, PMID: 25127217
12. Dalla Costa AP, Clemente CF, Carvalho HF, Carvalheira JB, Nadruz W, Franchini KG. 2010. FAK mediates the activation of cardiac fibroblasts induced by mechanical stress through regulation of the mTOR complex. Cardiovascular Research 86:421–431. doi: 10.1093/cvr/cvp416, PMID: 20038548
13. Dandel M, Lehmkuhl H, Knosalla C, Suramelashvili N, Hetzer R. 2009. Strain and strain rate imaging by echocardiography-basic concepts and clinical applicability. Current Cardiology Reviews 5:133–148. doi: 10.2174/157340309788166642, PMID: 20436854
14. Dobaczewski M, Bujak M, Li N, Gonzalez-Quesada C, Mendoza LH, Wang XF, Frangogiannis NG. 2010. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circulation Research 107:418–428. doi: 10.1161/CIRCRESAHA.109.216101, PMID: 20522804
15. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, Elvassore N, Piccolo S. 2011. Role of YAP/TAZ in mechanotransduction. Nature 474:179–183. doi: 10.1038/nature10137, PMID: 21654799
16. Edgley AJ, Krum H, Kelly DJ. 2012. Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-b. Cardiovascular Therapeutics 30:e30–e40. doi: 10.1111/j.1755-5922.2010.00228.x
17. Eek C, Grenne B, Brunvand H, Aakhus S, Endresen K, Smiseth OA, Edvardsen T, Skulstad H. 2010. Strain echocardiography predicts acute coronary occlusion in patients with non-ST-segment elevation acute coronary syndrome. European Journal of Echocardiography 11:501–508. doi: 10.1093/ejechocard/jeq008, PMID: 201 85525
18. Fan D, Takawale A, Lee J, Kassiri Z. 2012. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis & Tissue Repair 5:15. doi: 10.1186/1755-1536-5-15, PMID: 22943504
19. Flachskampf FA, Schmid M, Rost C, Achenbach S, DeMaria AN, Daniel WG. 2011. Cardiac imaging after myocardial infarction. European Heart Journal 32:272–283. doi: 10.1093/eurheartj/ehq446, PMID: 21163851
20. Frangogiannis NG. 2014. The inflammatory response in myocardial injury, repair, and remodelling. Nature Reviews Cardiology 11:255–265. doi: 10.1038/nrcardio.2014.28, PMID: 24663091
21. Frantz S, Hofmann U, Fraccarollo D, Schäfer A, Kranepuhl S, Hagedorn I, Nieswandt B, Nahrendorf M, Wagner H, Bayer B, Pachel C, Schön MP, Kneitz S, Bobinger T, Weidemann F, Ertl G, Bauersachs J. 2013. Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction. The FASEB Journal 27:871–881. doi: 10.1096/fj.12-214049, PMID: 23159933
22. Gao Q, Guo M, Zeng W, Wang Y, Yang L, Pang X, Li H, Suo Y, Jiang X, Yu C. 2015. Matrix metalloproteinase 9 secreted by hypoxia cardiac fibroblasts triggers cardiac stem cell migration in vitro. Stem Cells International 2015:836390–12. doi: 10.1155/2015/836390, PMID: 25767513
23. Gao Y, Chu M, Hong J, Shang J, Xu D. 2014. Hypoxia induces cardiac fibroblast proliferation and phenotypic switch: a role for caveolae and caveolin-1/PTEN mediated pathway. Journal of Thoracic Disease 6:1458–1468. doi: 10.3978/j.issn.2072-1439.2014.08.31, PMID: 25364523
24. Gonschior P, Gonschior GM, Conzen PF, Hobbhahn J, Goetz AE, Peter K, Brendel W. 1992. Myocardial oxygenation and transmural lactate metabolism during experimental acute coronary stenosis in pigs. Basic Research in Cardiology 87:27–37. doi: 10.1007/BF00795387, PMID: 1567351
25. Gu J, Liu X, Wang QX, Tan HW, Guo M, Jiang WF, Zhou L, xing WQ, wei TH, feng JW. 2012. Angiotensin II increases CTGF expression via MAPKs/TGF-b1/TRAF6 pathway in atrial fibroblasts. Experimental Cell Research 318:2105–2115. doi: 10.1016/j.yexcr.2012.06.015, PMID: 22749815
26. Guillén I, Blanes M, Gómez-Lechón MJ, Castell JV. 1995. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. The American Journal of Physiology 269:R229–235. PMID: 7544543
27. Guo XG, Uzui H, Mizuguchi T, Ueda T, Chen JZ, Lee JD. 2008. Imidaprilat inhibits matrix metalloproteinase-2 activity in human cardiac fibroblasts induced by interleukin-1beta via NO-dependent pathway. International Journal of Cardiology 126:414–420. doi: 10.1016/j.ijcard.2007.08.134, PMID: 18192036
28. Guo Y, Dong Z, Shi Y, Wang W, Wang L, Sun J, Sun X, Tian Z, Yao J, Li Z, Cheng J, Tian Y. 2016. Sonodynamic therapy inhibits fibrogenesis in rat cardiac fibroblasts induced by TGF-β1. Cellular Physiology and Biochemistry 40:579–588. doi: 10.1159/000452571, PMID: 27889772
29. Heusch G, Libby P, Gersh B, Yellon D, Böhm M, Lopaschuk G, Opie L. 2014. Cardiovascular remodelling in coronary artery disease and heart failure. The Lancet 383:1933–1943. doi: 10.1016/S0140-6736(14)60107-0, PMID: 24831770
30. Hoit BD. 2011. Strain and strain rate echocardiography and coronary artery disease. Circulation: Cardiovascular Imaging 4:179–190. doi: 10.1161/CIRCIMAGING.110.959817, PMID: 21406664
31. Humeres C, Vivar R, Boza P, Muñoz C, Bolivar S, Anfossi R, Osorio JM, Olivares-Silva F, García L, Díaz-Araya G. 2016. Cardiac fibroblast cytokine profiles induced by proinflammatory or profibrotic stimuli promote monocyte recruitment and modulate macrophage M1/M2 balance in vitro. Journal of Molecular and Cellular Cardiology 101:69–80. doi: 10.1016/j.yjmcc.2016.10.014, PMID: 27983968
32. Husse B, Briest W, Homagk L, Isenberg G, Gekle M. 2007. Cyclical mechanical stretch modulates expression of collagen I and collagen III by PKC and tyrosine kinase in cardiac fibroblasts. AJP: Regulatory, Integrative and Comparative Physiology 293:R1898–R1907. doi: 10.1152/ajpregu.00804.2006, PMID: 17686880
33. Kania G, Blyszczuk P, Eriksson U. 2009. Mechanisms of cardiac fibrosis in inflammatory heart disease. Trends in Cardiovascular Medicine 19:247–252. doi: 10.1016/j.tcm.2010.02.005, PMID: 20447565
34. Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J, Hongo M, Noda T, Nakayama J, Sagara J, Taniguchi S, Ikeda U. 2011. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 123:594–604. doi: 10.1161/CIRCULATIONAHA.110.982777, PMID: 21282498
35. Koizumi T, Komiyama N, Nishimura S. 2015. In-Vivo higher plasma levels of Platelet-Derived growth factor and matrix metalloproteinase-9 in coronary artery at the very onset of myocardial infarction with ST-Segment elevation. Annals of Vascular Diseases 8:297–301. doi: 10.3400/avd.oa.15-00057, PMID: 26730254
36. Krenning G, Zeisberg EM, Kalluri R. 2010. The origin of fibroblasts and mechanism of cardiac fibrosis. Journal of Cellular Physiology 225:631–637. doi: 10.1002/jcp.22322, PMID: 20635395
37. Leask A. 2007. TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovascular Research 74:207–212. doi: 10.1016/j.cardiores.2006.07.012, PMID: 16919613
38. Leask A. 2010. Potential therapeutic targets for cardiac fibrosis: tgfbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circulation Research 106:1675–1680. doi: 10.1161/CIRCRESAHA.110.217737, PMID: 20538689
39. Li R, Xiao J, Qing X, Xing J, Xia Y, Qi J, Liu X, Zhang S, Sheng X, Zhang X, Ji X. 2015. Sp1 mediates a therapeutic role of MiR-7a/b in angiotensin II-Induced cardiac fibrosis via mechanism involving the TGF-β and MAPKs pathways in cardiac fibroblasts. PLoS One 10:e0125513. doi: 10.1371/journal.pone.0125513, PMID: 25923922
40. Liao XD, Wang XH, Jin HJ, Chen LY, Chen Q. 2004. Mechanical stretch induces mitochondria-dependent apoptosis in neonatal rat cardiomyocytes and G2/M accumulation in cardiac fibroblasts. Cell Research 14:16–26. doi: 10.1038/sj.cr.7290198, PMID: 15040886
41. Lijnen PJ, Petrov VV, Fagard RH. 2000. Induction of cardiac fibrosis by transforming growth factor-beta(1). Molecular Genetics and Metabolism 71:418–435. doi: 10.1006/mgme.2000.3032, PMID: 11001836
42. Lindner D, Zietsch C, Tank J, Sossalla S, Fluschnik N, Hinrichs S, Maier L, Poller W, Blankenberg S, Schultheiss H-P, Tschöpe C, Westermann D. 2014. Cardiac fibroblasts support cardiac inflammation in heart failure. Basic Research in Cardiology 109:1–16. doi: 10.1007/s00395-014-0428-7
43. Liu C, Zhao W, Meng W, Zhao T, Chen Y, Ahokas RA, Liu H, Sun Y. 2014. Platelet-derived growth factor blockade on cardiac remodeling following infarction. Molecular and Cellular Biochemistry 397:295–304. doi: 10.1007/s11010-014-2197-x, PMID: 25148874
44. Marsano A, Conficconi C, Lemme M, Occhetta P, Gaudiello E, Votta E, Cerino G, Redaelli A, Rasponi M. 2016. Beating heart on a chip: a novel microfluidic platform to generate functional 3D cardiac microtissues. Lab Chip 16:599–610. doi: 10.1039/C5LC01356A, PMID: 26758922
45. Mollema SA, Delgado V, Bertini M, Antoni ML, Boersma E, Holman ER, Stokkel MP, van der Wall EE, Schalij MJ, Bax JJ. 2010. Viability assessment with global left ventricular longitudinal strain predicts recovery of left ventricular function after acute myocardial infarction. Circulation: Cardiovascular Imaging 3:15–23. doi: 10.1161/CIRCIMAGING.108.802785, PMID: 19820202
46. Morishita T, Uzui H, Mitsuke Y, Arakawa K, Amaya N, Kaseno K, Ishida K, Nakaya R, Lee JD, Tada H. 2015. Predictive utility of the changes in matrix metalloproteinase-2 in the early phase for left ventricular reverse remodeling after an acute myocardial infarction. Journal of the American Heart Association 4:e001359. doi: 10.1161/JAHA.114.001359, PMID: 25616975
47. Mosqueira D, Pagliari S, Uto K, Ebara M, Romanazzo S, Escobedo-Lucea C, Nakanishi J, Taniguchi A, Franzese O, Di Nardo P, Goumans MJ, Traversa E, Pinto-do-Ó; P, Aoyagi T, Forte G. 2014. Hippo pathway effectors control cardiac progenitor cell fate by acting as dynamic sensors of substrate mechanics and nanostructure. ACS Nano 8:2033–2047. doi: 10.1021/nn4058984, PMID: 24483337
48. Nahrendorf M, Pittet MJ, Swirski FK. 2010. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121:2437–2445. doi: 10.1161/CIRCULATIONAHA.109.916346, PMID: 20530020
49. Okada H, Takemura G, Kosai K, Li Y, Takahashi T, Esaki M, Yuge K, Miyata S, Maruyama R, Mikami A, Minatoguchi S, Fujiwara T, Fujiwara H. 2005. Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure. Circulation 111:2430–2437. doi: 10.1161/01.CIR.0000165066.71481.8E, PMID: 15867170
50. Pan X, Chen Z, Huang R, Yao Y, Ma G. 2013. Transforming growth factor b1 induces the expression of collagen type I by DNA methylation in cardiac fibroblasts. PLoS One 8:e60335. doi: 10.1371/journal.pone.0060335, PMID: 23560091
51. Papizan JB, Olson EN. 2014. Hippo in the path to heart repair. Circulation Research 115:332–334. doi: 10.1161/CIRCRESAHA.114.304389, PMID: 25035132
52. Pavesi A, Adriani G, Rasponi M, Zervantonakis IK, Fiore GB, Kamm RD. 2015. Controlled electromechanical cell stimulation on-a-chip. Scientific Reports 5:11800. doi: 10.1038/srep11800, PMID: 26135970
53. Peng H, Carretero OA, Peterson EL, Rhaleb NE. 2010. Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts. AJP: Heart and Circulatory Physiology 298:H1357–H1364. doi: 10.1152/ajpheart.00464.2009
54. Petrov VV, Fagard RH, Lijnen PJ. 2002. Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension 39:258–263. doi: 10.1161/hy0202.103268, PMID: 11847194
55. Pfeffer MA, Braunwald E. 1990. Ventricular remodeling after myocardial infarction. experimental observations and clinical implications. Circulation 81:1161–1172. doi: 10.1161/01.CIR.81.4.1161, PMID: 2138525
56. Picard MH, Wilkins GT, Ray PA, Weyman AE. 1990. Natural history of left ventricular size and function after acute myocardial infarction. assessment and prediction by echocardiographic endocardial surface mapping. Circulation 82:484–494. doi: 10.1161/01.CIR.82.2.484, PMID: 2372895
57. Porter KE, Turner NA, O’Regan DJ, Ball SG. 2004. Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. Cardiovascular Research 64:507–515. doi: 10.1016/j.cardiores.2004.07.020, PMID: 15537504
58. Porter KE, Turner NA. 2009. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacology & Therapeutics 123:255–278. doi: 10.1016/j.pharmthera.2009.05.002, PMID: 19460403
59. Rhaleb NE, Pokharel S, Sharma UC, Peng H, Peterson E, Harding P, Yang XP, Carretero OA. 2013. N-acetyl-Ser-Asp-Lys-Pro inhibits interleukin-1b-mediated matrix metalloproteinase activation in cardiac fibroblasts. Pflügers Archiv-European Journal of Physiology 465:1487–1495. doi: 10.1007/s00424-013-1262-8, PMID: 23652767
60. Riches K, Morley ME, Turner NA, O’Regan DJ, Ball SG, Peers C, Porter KE. 2009. Chronic hypoxia inhibits MMP-2 activation and cellular invasion in human cardiac myofibroblasts. Journal of Molecular and Cellular Cardiology 47:391–399. doi: 10.1016/j.yjmcc.2009.06.002, PMID: 19523958
61. Roubille F, Busseuil D, Merlet N, Kritikou EA, Rhéaume E, Tardif JC. 2014. Investigational drugs targeting cardiac fibrosis. Expert Review of Cardiovascular Therapy 12:111–125. doi: 10.1586/14779072.2013.839942, PMID: 24218990
62. Roy S, Khanna S, Bickerstaff AA, Subramanian SV, Atalay M, Bierl M, Pendyala S, Levy D, Sharma N, Venojarvi M, Strauch A, Orosz CG, Sen CK. 2003. Oxygen sensing by primary cardiac fibroblasts: a key role of p21(Waf1/Cip1/Sdi1). Circulation Research 92:264–271. doi: 10.1161/01.RES.0000056770.30922.E6, PMID: 12595337
63. Santiago JJ, Dangerfield AL, Rattan SG, Bathe KL, Cunnington RH, Raizman JE, Bedosky KM, Freed DH, Kardami E, Dixon IM. 2010. Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Developmental Dynamics 239:1573–1584. doi: 10.1002/dvdy.22280, PMID: 20503355
64. Schroer AK, Merryman WD. 2015. Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease. Journal of Cell Science 128:1865–1875. doi: 10.1242/jcs.162891, PMID: 25918124
65. Sen CK, Khanna S, Roy S. 2006. Perceived hyperoxia: oxygen-induced remodeling of the reoxygenated heart. Cardiovascular Research 71:280–288. doi: 10.1016/j.cardiores.2006.01.003, PMID: 16483558
66. Sen CK, Roy S. 2010. Oxygenation state as a driver of myofibroblast differentiation and wound contraction: hypoxia impairs wound closure. Journal of Investigative Dermatology 130:2701–2703. doi: 10.1038/jid.2010.316, PMID: 21068734
67. Shinde AV, Frangogiannis NG. 2014. Fibroblasts in myocardial infarction: a role in inflammation and repair. Journal of Molecular and Cellular Cardiology 70:74–82. doi: 10.1016/j.yjmcc.2013.11.015, PMID: 24321195
68. Siwik DA, Chang DL, Colucci WS. 2000. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circulation Research 86: 1259–1265. doi: 10.1161/01.RES.86.12.1259, PMID: 10864917
69. Stawowy P, Margeta C, Kallisch H, Seidah NG, Chrétien M, Fleck E, Graf K. 2004. Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-beta1 involves furin-convertase. Cardiovascular Research 63:87–97. doi: 10.1016/j.cardiores.2004.03.010, PMID: 15194465
70. Talman V, Ruskoaho H. 2016. Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell and Tissue Research 365:563–581. doi: 10.1007/s00441-016-2431-9, PMID: 27324127
71. Tamamori M, Ito H, Hiroe M, Marumo F, Hata RI. 1997. Stimulation of collagen synthesis in rat cardiac fibroblasts by exposure to hypoxic culture conditions and suppression of the effect by natriuretic peptides. Cell Biology International 21:175–180. doi: 10.1006/cbir.1997.0130, PMID: 9151994
72. Tennant R, Wiggers CJ. 1935. The effect of coronary occlusion on myocardial contraction. Am. J. Physiol.-Hear. Circ. Physiol 112:351–361. doi: 10.1016/S0002-8703(35)90365-9
73. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. 2002. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nature Reviews Molecular Cell Biology 3:349–363. doi: 10.1038/nrm809, PMID: 11988769
74. Tsoporis JN, Izhar S, Proteau G, Slaughter G, Parker TG. 2012. S100B-RAGE dependent VEGF secretion by cardiac myocytes induces myofibroblast proliferation. Journal of Molecular and Cellular Cardiology 52:464–473. doi: 10.1016/j.yjmcc.2011.08.015, PMID: 21889514
75. Turner NA, Das A, Warburton P, O’Regan DJ, Ball SG, Porter KE. 2009. Interleukin-1alpha stimulates proinflammatory cytokine expression in human cardiac myofibroblasts. AJP: Heart and Circulatory Physiology 297:H1117–H1127. doi: 10.1152/ajpheart.00372.2009, PMID: 19648252
76. Turner NA, Mughal RS, Warburton P, O’Regan DJ, Ball SG, Porter KE. 2007. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones. Cardiovascular Research 76:81–90. doi: 10.1016/j.cardiores.2007.06.003, PMID: 17612514
77. Turner NA. 2014. Effects of interleukin-1 on cardiac fibroblast function: relevance to post-myocardial infarction remodelling. Vascular Pharmacology 60:1–7. doi: 10.1016/j.vph.2013.06.002, PMID: 23806284
78. Turner NA. 2016. Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs). Journal of Molecular and Cellular Cardiology 94:189–200. doi: 10.1016/j.yjmcc.2015.11.002, PMID: 26542796
79. Tyagi SC, Lewis K, Pikes D, Marcello A, Mujumdar VS, Smiley LM, Moore CK. 1998. Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells. Journal of Cellular Physiology 176:374–382. doi: 10.1002/(SICI)1097-4652(199808)176:2<374::AID-JCP16>3.0.CO;2-3, PMID: 964 8925
80. Ugolini GS, Rasponi M, Pavesi A, Santoro R, Kamm R, Fiore GB, Pesce M, Soncini M. 2016. On-chip assessment of human primary cardiac fibroblasts proliferative responses to uniaxial cyclic mechanical strain. Biotechnology and Bioengineering 113:859–869 http://www.ncbi.nlm.nih.gov/pubmed/26444553. doi: 10.1002/bit.25847, PMID: 26444553
81. Uzel SG, Pavesi A, Kamm RD. 2014. Microfabrication and microfluidics for muscle tissue models. Progress in Biophysics and Molecular Biology 115:279–293. doi: 10.1016/j.pbiomolbio.2014.08.013, PMID: 25175338
82. van Amerongen MJ, Harmsen MC, van Rooijen N, Petersen AH, van Luyn MJ. 2007. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. The American Journal of Pathology 170:818–829. doi: 10.2353/ajpath.2007.060547, PMID: 17322368
83. van Nieuwenhoven FA, Hemmings KE, Porter KE, Turner NA. 2013. Combined effects of interleukin-1a and transforming growth factor-b1 on modulation of human cardiac fibroblast function. Matrix Biology 32:399–406. doi: 10.1016/j.matbio.2013.03.008, PMID: 23583823
84. Vartdal T, Brunvand H, Pettersen E, Smith HJ, Lyseggen E, Helle-Valle T, Skulstad H, Ihlen H, Edvardsen T. 2007. Early prediction of infarct size by strain doppler echocardiography after coronary reperfusion. Journal of the American College of Cardiology 49:1715–1721. doi: 10.1016/j.jacc.2006.12.047, PMID: 17448374
85. Vivar R, Humeres C, Muñoz C, Boza P, Bolivar S, Tapia F, Lavandero S, Chiong M, Diaz-Araya G. 2016. FoxO1 mediates TGF-beta1-dependent cardiac myofibroblast differentiation. Biochimica Et Biophysica Acta (BBA)-Molecular Cell Research 1863:128–138. doi: 10.1016/j.bbamcr.2015.10.019
86. Winegrad S, Henrion D, Rappaport L, Samuel JL. 1999. Self-protection by cardiac myocytes against hypoxia and hyperoxia. Circulation Research 85:690–698. doi: 10.1161/01.RES.85.8.690, PMID: 10521242
87. Xiao J, Sheng X, Zhang X, Guo M, Ji X. 2016. Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro. Drug Design, Development and Therapy 10:1267–1277. doi: 10.2147/DDDT.S104925, PMID: 27099472
88. Xin M, Kim Y, Sutherland LB, Murakami M, Qi X, McAnally J, Porrello ER, Mahmoud AI, Tan W, Shelton JM, Richardson JA, Sadek HA, Bassel-Duby R, Olson EN. 2013. Hippo pathway effector yap promotes cardiac regeneration. PNAS 110:13839–13844. doi: 10.1073/pnas.1313192110, PMID: 23918388
89. Yokoyama T, Sekiguchi K, Tanaka T, Tomaru K, Arai M, Suzuki T, Nagai R. 1999. Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts. Journal of Cardiac Failure 276:44–H1976. doi: 10.1016/S1071-9164(99)91145-4, PMID: 10362677
90. Zhang P, Su J, Mende U. 2012. Cross talk between cardiac myocytes and fibroblasts: from multiscale investigative approaches to mechanisms and functional consequences. AJP: Heart and Circulatory Physiology 303:H1385–H1396. doi: 10.1152/ajpheart.01167.2011
91. Zhao W, Zhao T, Huang V, Chen Y, Ahokas RA, Sun Y. 2011. Platelet-derived growth factor involvement in myocardial remodeling following infarction. Journal of Molecular and Cellular Cardiology 51:830–838. doi: 10.1016/j.yjmcc.2011.06.023, PMID: 21767547